Minutes of a Board Meeting held at the Registered Office of

BIOGEN PHARMA LIMITED

On Monday 14 August 2023 at 9.30 a.m.

Present:
Sr. Name & Designation (BIOGEN
No. PHARMA LTD.)
1 Mr. Aadithya Premraj (CEO)
2 Mr. Aves Ansari (CFO)
3 Ms. Natasha Kairamkonda (COO)
4 Mr. Adil Mohammed (CLO)
5 Ms. Mrunmayee Hegiste (CHR)
Sr. Name & Designation (MEDLABS
No. PVT. LTD.)
6 Ms. Sharvari Indalkar (CEO)
7 Mr. Devang Gada (CFO)
8 Mr. Atharva Jindal (COO)
9 Mr. Raviraj Khandekar (CLO)

In Attendance:
1. Mr. Jatin Gola (Secretary)
Apologies for absence was received from Mr. Darsh Chotalia (CHR) & Mr. Danish (Solicitor)

1.01 Introduction of the new committee following the merger

Mr. Jatin started with greeting the board, taking attendance and introducing the members present
in the meeting.
1.02 Formation of the New Board of the Directors
Mr. Aadithya and Ms. Sharvari spoke about the formation of the new board of the merged
company and it was decided that the board will consist of the same people and there are no
changes in the designations of the board members from both the companies.
1.03 Asset distribution discussion
Mr. Aves spoke the about the financial status of Biogen Pharma then Mr. Devang added to it and
spoke about shares distribution between the two companies, profit distribution between the two
companies.
Mr. Raviraj and Mr. Adil discussed the laws and govt. permissions that are already taken related
to it.
1.04 Employee engagement strategy deliberation
Ms. Mrunmayee discussed about employees positioning and declared that there is no layoff
taking place in the company further adding to it she discussed to keep team building activities to
make the employees know and easily work with each other as a team. Also exploring ways to
enhance our training offerings, including access to resources from both companies.
1.05 Salary Planning for the Future
CFOs discussed that the pay remains the same unless and until someone’s designation or work
load is changed in a considerable manner. And it was decided if so happens then the changes in
the salary would be done.
Adding to this the CLO’s stated that new agreement bond will be made accordingly following all
the rules and regulations and stated about employee provident fund, employee state insurance,
gratuity, maternity benefit act (paid maternity leave for female employees), etc. and the govt.
guidelines that will be followed while paying the salary to the employee.
1.06 Setting long term goals
Ms. Natasha discussed about how the merger has provided them with many opportunities adding
to which Mr. Atharva stated that for now Medlabs sales are quite low but their production
method is very efficient and updated after merging with Biogen Pharma which has been in the
market for 5 centuries has good goodwill and a good market capture is going to help them
increase their sales, profits and develop our companies more strongly as one.
Noted to work more on R&D which will help in more quality product in less production cost.
Noted looking forward to make their products cheaply and easily available to the people that stay
in rural areas and are below poverty line.
Ms. Mrunmayee spoke on exploring ways to enhance our training offerings.
1.07 Next meeting date finalization.
The date of the next meeting of the board of directors would be on Thursday 14 September 2023.
In the absence of any other business the meeting closed at 9.56 a.m.
1.08 Vote of Thanks

Jatin Gola Ms. Sharvari Indalkar Mr. Aadithya Premraj

Secretary CEO (Medlabs) CEO (Biogen Pharma)
September 14, 2023 September 14, 2023 September 14, 2023